• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部用皮质类固醇的现行治疗指南。

Current treatment guidelines for topical corticosteroids.

作者信息

Giannotti B

机构信息

Clinica Dermatologica II, University of Florence, Italy.

出版信息

Drugs. 1988;36 Suppl 5:9-14. doi: 10.2165/00003495-198800365-00004.

DOI:10.2165/00003495-198800365-00004
PMID:3076133
Abstract

The effectiveness of a topical corticosteroid is related to various factors which should be considered when planning treatment. The most relevant factor is the potency of the drug. Another important factor is the absorption through the skin, which is influenced by marked regional variations in percutaneous penetration, hydration and the degree of inflammation present, types of dressings, the solubility of the drug and the age of the patient. Multiple daily applications do not lead to better or faster resolution of the disease. Intermittent therapy with treatment-free intervals, when the vehicle alone is applied, can be as effective as continuous treatment. The choice of a topical corticosteroid depends not only on the severity or activity of the disease, but also on the age of the subject, the body site affected and the extent of the surface area to be treated. In addition, the choice of vehicle depends on the type of lesion and on the body region afflicted. Combinations of a corticosteroid with other agents can be useful, but they are recommended in only a few specific indications. Treatment guidelines for topical corticosteroids must therefore take into account a number of factors which will influence the clinician's ultimate decision in providing care for the patient with steroid-responsive dermatoses.

摘要

局部用皮质类固醇的疗效与多种因素有关,在制定治疗方案时应予以考虑。最相关的因素是药物的效力。另一个重要因素是经皮肤吸收,这受到经皮渗透、水合作用、炎症程度、敷料类型、药物溶解度和患者年龄等显著区域差异的影响。每日多次用药并不会使疾病得到更好或更快的缓解。当仅使用基质时,采用有停药间隔的间歇疗法与持续治疗同样有效。局部用皮质类固醇的选择不仅取决于疾病的严重程度或活动度,还取决于受试者的年龄、受累身体部位以及待治疗的表面积大小。此外,基质的选择取决于皮损类型和受累身体区域。皮质类固醇与其他药物联合使用可能有用,但仅在少数特定适应证中推荐。因此,局部用皮质类固醇的治疗指南必须考虑许多因素,这些因素将影响临床医生为患有类固醇反应性皮肤病的患者提供护理时的最终决策。

相似文献

1
Current treatment guidelines for topical corticosteroids.局部用皮质类固醇的现行治疗指南。
Drugs. 1988;36 Suppl 5:9-14. doi: 10.2165/00003495-198800365-00004.
2
Clinical pharmacology and pharmacokinetic properties of topically applied corticosteroids. A review.局部应用皮质类固醇的临床药理学和药代动力学特性。综述。
Drugs. 1988;36 Suppl 5:51-61. doi: 10.2165/00003495-198800365-00011.
3
Topical corticosteroids. Which drug and when?外用糖皮质激素。用哪种药物以及何时使用?
Drugs. 1992 Jul;44(1):65-71. doi: 10.2165/00003495-199244010-00006.
4
A clinician's paradigm in the treatment of atopic dermatitis.临床医生治疗特应性皮炎的范例。
J Am Acad Dermatol. 2005 Jul;53(1 Suppl 1):S70-7. doi: 10.1016/j.jaad.2005.04.032.
5
Corticosteroids: options in the era of steroid-sparing therapy.皮质类固醇:类固醇节省疗法时代的选择
J Am Acad Dermatol. 2005 Jul;53(1 Suppl 1):S50-8. doi: 10.1016/j.jaad.2005.04.030.
6
Clinical potential of topical corticosteroids.局部用皮质类固醇的临床潜力。
Drugs. 1988;36 Suppl 5:38-42. doi: 10.2165/00003495-198800365-00008.
7
[Local corticosteroid therapy in dermatology].[皮肤科局部皮质类固醇治疗]
Presse Med. 1999 Nov 27;28(37):2050-6.
8
[Lack of compliance to topical corticosteroid therapy: possible cause and solutions].[外用糖皮质激素治疗依从性差:可能原因及解决方法]
J Pharm Belg. 2013 Mar(1):20-7.
9
[Constitutional eczema; the possibilities of local treatment].[体质性湿疹;局部治疗的可能性]
Ned Tijdschr Geneeskd. 2002 Mar 2;146(9):400-4.
10
A novel foam vehicle for delivery of topical corticosteroids.一种用于递送局部用皮质类固醇的新型泡沫载体。
J Am Acad Dermatol. 2005 Jul;53(1 Suppl 1):S26-38. doi: 10.1016/j.jaad.2005.04.028.

引用本文的文献

1
Systematic review of Flegel disease: clinical presentations, associations, diagnostic pitfalls, and management challenges.弗勒格尔病的系统评价:临床表现、关联因素、诊断陷阱及管理挑战
Arch Dermatol Res. 2025 May 16;317(1):766. doi: 10.1007/s00403-025-04268-x.
2
Kyrle disease: a systematic review of clinical features, diagnostic approaches, dermatoscopic insights, systemic associations, and therapeutic strategies.Kyrle病:临床特征、诊断方法、皮肤镜观察、全身关联及治疗策略的系统评价
Arch Dermatol Res. 2025 Mar 23;317(1):622. doi: 10.1007/s00403-025-04067-4.
3
Ethical use of topical corticosteroids.

本文引用的文献

1
Analysis of the results obtained in the treatment of atopic dermatitis with corticosteroid and neomycin containing ointments.含皮质类固醇和新霉素软膏治疗特应性皮炎所得结果的分析。
Dermatologica. 1960 Apr;120:191-9. doi: 10.1159/000255315.
2
EXISTENCE OF RESERVOIR IN THE STRATUM CORNEUM. EXPERIMENTAL PROOF.角质层中储存库的存在。实验证据。
Arch Dermatol. 1963 Jul;88:20-3. doi: 10.1001/archderm.1963.01590190026002.
3
Topical corticosteroids: clinical pharmacology and therapeutic use.局部用皮质类固醇:临床药理学与治疗应用。
外用糖皮质激素的合理使用。
Indian J Dermatol. 2014 Sep;59(5):469-72. doi: 10.4103/0019-5154.139877.
4
Rational and ethical use of topical corticosteroids based on safety and efficacy.基于安全性和有效性合理且符合伦理地使用外用糖皮质激素。
Indian J Dermatol. 2012 Jul;57(4):251-9. doi: 10.4103/0019-5154.97655.
5
Topical corticosteroids and unwanted local effects. Improving the benefit/risk ratio.外用皮质类固醇与不良局部效应。改善效益/风险比。
Drug Saf. 1994 May;10(5):406-12. doi: 10.2165/00002018-199410050-00005.
6
Topical corticosteroids. Which drug and when?外用糖皮质激素。用哪种药物以及何时使用?
Drugs. 1992 Jul;44(1):65-71. doi: 10.2165/00003495-199244010-00006.
Drugs. 1980 Feb;19(2):119-34. doi: 10.2165/00003495-198019020-00004.
4
Treatment of psoriasis and atopic dermatitis with halcinonide cream applied once and three times daily.用哈西奈德乳膏每日一次和每日三次涂抹治疗银屑病和特应性皮炎。
Br J Dermatol. 1980 May;102(5):575-7. doi: 10.1111/j.1365-2133.1980.tb07658.x.
5
Comparison of two application schedules for clobetasol 17 propionate.丙酸氯倍他索两种用药方案的比较。
Acta Derm Venereol. 1982;62(3):270-3.
6
Topical steroid-antibiotic combinations: assay of use in experimentally induced human infections.
Arch Dermatol. 1973 Aug;108(2):237-40. doi: 10.1001/archderm.108.2.237.
7
Editorial: Topical corticosteroid therapy: efficacy of frequent application.社论:局部皮质类固醇疗法:频繁应用的疗效
Arch Dermatol. 1974 Dec;110(6):955-6.
8
The value of neomycin in a neomycin-steroid cream.
JAMA. 1968 Jan 22;203(4):298-300.
9
The value of neomycin in topical corticosteroid preparations.
South Med J. 1969 Jan;62(1):94-6. doi: 10.1097/00007611-196901000-00021.
10
Is steroid tachyphylaxis preventable?类固醇快速减敏反应可预防吗?
Clin Exp Dermatol. 1985 Jan;10(1):22-9. doi: 10.1111/j.1365-2230.1985.tb02547.x.